HLA-C and neoplasm: However, due to factors such as defective tumor antigen release, impaired T-cell priming in local lymph nodes, and tumor immunosuppressive signals (such as the downregulation of MHC expression by tumor cells) that enable tumor cells to escape immune surveillance, the cancer-immunity cycle may be impaired, causing tumor progression (20).